# Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)

> **NCT07657988** · — · RECRUITING · sponsor: **Avant Health LLC** · enrollment: 30 (estimated)

## Conditions studied

- Actinic Keratosis (AK)

## Interventions

- **DRUG:** Tirbanibulin

## Key facts

- **NCT ID:** NCT07657988
- **Lead sponsor:** Avant Health LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2026-10
- **Final completion:** 2026-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07657988

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07657988, "Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07657988. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*